BioSpace News Archive

A preliminary study suggests that Black people who have autoimmune neurologic diseases, multiple sclerosis and neuromyelitis optica spectrum disorder, may respond differently than white people to a common therapy meant to modulate the immune system.

Virios Therapeutics, Inc., a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced an interview with Chairman and CEO, Greg Duncan, will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, April 17, 2021 at 7 p.m.

UCB reinforces commitment to delivering increased patient value by presenting latest research findings in epilepsy, myasthenia gravis, and Parkinson’s disease

AVEO Oncology, a commercial and clinical development stage biopharmaceutical company, announced the appointment of Kevin J. Cullen, M.D., to the Company’s Board of Directors.

Labcorp, a leading global life sciences company, announced that its Annual Meeting of Shareholders will be webcast live beginning May 12, at 9:00 a.m. ET via the company website at www.Labcorp.com.

For several decades, veterinary vaccines have played a key role in improving food security and as a result, human health.

The increasing cases of kidney, liver, and heart diseases are likely to aid in expansion of the global alagille syndrome treatment market.

The changing lifestyle of people and the wide adoption of sedentary lifestyle propelled the prevalence of various skin and scalp disorders.

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce that the Company has secured its first large-scale pharma services contract.

Medivir AB announced that its Board of Directors appoints Magnus Christensen, the company’s CFO, as interim CEO of Medivir.